Should all diabetic patients be treated with a statin?

Diabetes care

Volumn 32 Suppl 2, Issue , 2009, Pages

  Kamari, Yehuda ^a   Bitzur, Rafael ^a   Cohen, Hofit ^a   Shaish, Aviv ^a   Harats, Dror ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HUMAN; PREVALENCE; REVIEW; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PREVALENCE; RISK ASSESSMENT;

MLCS; MLOWN;

EID: 75549090955     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-s344     Document Type: Review

References (41)